Does Neogen's (NEOG) CFO Transition Signal a New Phase for Its Financial Strategy? [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
Vice President, effective November 3, 2025, succeeding David Naemura who will remain through year-end for a smooth transition. Riggsbee brings more than 25 years of financial leadership experience from key roles at bioMérieux and Myriad Genetics, adding significant industry expertise to Neogen's executive team. We will look at how Riggsbee's extensive diagnostics finance background could influence Neogen's operational execution and investment case. This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality Neogen Investment Narrative Recap Neogen's investment thesis relies on the company's potential to capitalize on growing demand for food safety and animal health solutions while executing operational improvements following its significant acquisition of 3M's Food Safety business. The appointment of Bryan Riggsbee as CFO, given his depth in diagnostics finance, does not materially alter the immediate catalyst for the stoc
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Why Myriad Genetics (MYGN) Stock Is Trading Lower Today [Yahoo! Finance]Yahoo! Finance
- How Recent Developments Are Shaping the Myriad Genetics Investment Story [Yahoo! Finance]Yahoo! Finance
- Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health [Yahoo! Finance]Yahoo! Finance
- Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast HealthGlobeNewswire
- Myriad Genetics (NASDAQ:MYGN) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
MYGN
Earnings
- 11/3/25 - Beat
MYGN
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/12/25 - Form SCHEDULE
- 11/4/25 - Form 4
- MYGN's page on the SEC website